Q1 EPS Forecast for Jazz Pharmaceuticals Raised by Analyst
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for shares of Jazz Pharmaceuticals in a research report issued to clients and investors on Tuesday, March 18th. Zacks Research analyst S. Ganoria now forecasts that the specialty pharmaceutical company will post earnings of […]
